ForSight Robotics secures $125M to advance its robotic surgery platform, targeting cataract procedures and additional ...

Danegaptide is an oral therapy for early treatment of non-proliferative diabetic retinopathy (NPDR) and associated edema.

Perfuse Therapeutics reveals promising Phase 2 trial results for PER-001, a potential treatment for glaucoma and diabetic ...

Intravitreal anti-VEGF agents effectively manage nAMD but require frequent injections, leading to poor adherence and ...

Recombinant tissue plasminogen activator (tPA)—a molecule approved for the treatment of acute stroke by the FDA in ...

As its director, Manusis outlines the facility’s role in delivering advanced, personalized solutions to improve vision and ...

From laser vision correction to adjustable lens implants, the Center for Refractive Solutions at New York Eye and Ear ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

Patients in Ontario expose illegal user fees for cataract surgeries in private clinics, urging government action to uphold ...

To conduct the study, the investigators obtained data on coffee consumption from genome‐wide association studies (GWAS) and ...

A look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive ...

Funding will support continued product development, while the board is composed of “global leaders in posterior and anterior ...